U.S. flag

An official website of the United States government

NM_018668.5(VPS33B):c.1509dup (p.Lys504fs) AND Arthrogryposis, renal dysfunction, and cholestasis 1

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Mar 22, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002052135.2

Allele description [Variation Report for NM_018668.5(VPS33B):c.1509dup (p.Lys504fs)]

NM_018668.5(VPS33B):c.1509dup (p.Lys504fs)

Gene:
VPS33B:VPS33B late endosome and lysosome associated [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
15q26.1
Genomic location:
Preferred name:
NM_018668.5(VPS33B):c.1509dup (p.Lys504fs)
HGVS:
  • NC_000015.10:g.91000562dup
  • NG_012162.1:g.27042dup
  • NM_001289148.1:c.1428dup
  • NM_001289149.1:c.1236dup
  • NM_018668.5:c.1509dupMANE SELECT
  • NP_001276077.1:p.Lys477fs
  • NP_001276078.1:p.Lys413fs
  • NP_061138.3:p.Lys504fs
  • LRG_884:g.27042dup
  • NC_000015.9:g.91543792dup
  • NM_018668.4:c.109dupG
Protein change:
K413fs
Links:
OMIM: 608552.0012; dbSNP: rs1209349503
NCBI 1000 Genomes Browser:
rs1209349503
Molecular consequence:
  • NM_001289148.1:c.1428dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001289149.1:c.1236dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_018668.5:c.1509dup - frameshift variant - [Sequence Ontology: SO:0001589]
Observations:
1

Condition(s)

Name:
Arthrogryposis, renal dysfunction, and cholestasis 1 (ARCS1)
Identifiers:
MONDO: MONDO:0008822; MedGen: C1859722; Orphanet: 2697; OMIM: 208085

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV0023186193billion
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Mar 22, 2022)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

SCV002564412OMIM
no assertion criteria provided
Pathogenic
(Aug 18, 2022)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot provided1not providedclinical testing
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Molecular investigations to improve diagnostic accuracy in patients with ARC syndrome.

Cullinane AR, Straatman-Iwanowska A, Seo JK, Ko JS, Song KS, Gizewska M, Gruszfeld D, Gliwicz D, Tuysuz B, Erdemir G, Sougrat R, Wakabayashi Y, Hinds R, Barnicoat A, Mandel H, Chitayat D, Fischler B, Garcia-Cazorla A, Knisely AS, Kelly DA, Maher ER, Gissen P.

Hum Mutat. 2009 Feb;30(2):E330-7. doi: 10.1002/humu.20900.

PubMed [citation]
PMID:
18853461
PMCID:
PMC2635429

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753
See all PubMed Citations (3)

Details of each submission

From 3billion, SCV002318619.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (2)

Description

Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. It is not observed in the gnomAD v2.1.1 dataset. This variant has been reported to be associated with VPS33B related disorder (PMID:18853461). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes1not providednot provided1not providednot providednot provided

From OMIM, SCV002564412.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

Progressive Familial Intrahepatic Cholestasis 12

For discussion of the 1-bp duplication (c.109dupG, NM_018668.4) in the VPS33B gene, causing a frameshift predicted to result in a premature termination codon (Lys504GlufsTer), that was found in compound heterozygous state in a Chinese brother (P2) and sister (P3) with isolated cholestasis (PFIC12; 610010) by Qiu et al. (2019), see 608552.0011.

Arthrogryposis, Renal Dysfunction, and Cholestasis 1

In a Chinese female infant (P4) who died at the age of 6 months with arthrogryposis, renal dysfunction, and cholestasis-1 (ARCS1; 208085), Qiu et al. (2019) identified compound heterozygosity for the c.109dupG mutation and a splice site mutation (c.403+2T-A; 608552.0013).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 24, 2023